Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Q Bernardini

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Journal of Endourology|February 27, 2016
Baseline Laparoscopic Skill May Predict Baseline Robotic Skill and Early Robotic Surgery Learning CurveRuaidhri McVey, Mitchell G Goldenberg, Marcus Q Bernardini, et al.
Gynecologic Oncology|October 31, 2025
Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatmentAuni Lindgren, Anouk Benseler, Liat Hogen, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 9, 2020
Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous CarcinomaMary Anne Brett, Eshetu G Atenafu, Nilanchali Singh, et al.
Surgical Oncology Clinics of North America|June 17, 2022
Leiomyosarcoma: Current Clinical Management and Future HorizonsNicolas Devaud, Olga Vornicova, Albiruni R Abdul Razak, et al.
Genes, Chromosomes & Cancer|August 26, 2018
Novel EPC1 gene fusions in endometrial stromal sarcomaBrendan C Dickson, Amy Lum, David Swanson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2023
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2022
Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypesAnnie H Ren, Panagiota S Filippou, Antoninus Soosaipillai, et al.
Clinical Proteomics|July 2, 2014
Deciphering the peptidome of urine from ovarian cancer patients and healthy controlsChristopher R Smith, Ihor Batruch, Josep Miquel Bauça, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 31, 2016
The optimal time for surgery in women with serous ovarian cancerJocelyn M Stewart, Alicia A Tone, Haiyan Jiang, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Journal of Endourology|February 27, 2016
Baseline Laparoscopic Skill May Predict Baseline Robotic Skill and Early Robotic Surgery Learning CurveRuaidhri McVey, Mitchell G Goldenberg, Marcus Q Bernardini, et al.
Gynecologic Oncology|October 31, 2025
Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatmentAuni Lindgren, Anouk Benseler, Liat Hogen, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 9, 2020
Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous CarcinomaMary Anne Brett, Eshetu G Atenafu, Nilanchali Singh, et al.
Surgical Oncology Clinics of North America|June 17, 2022
Leiomyosarcoma: Current Clinical Management and Future HorizonsNicolas Devaud, Olga Vornicova, Albiruni R Abdul Razak, et al.
Genes, Chromosomes & Cancer|August 26, 2018
Novel EPC1 gene fusions in endometrial stromal sarcomaBrendan C Dickson, Amy Lum, David Swanson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 4, 2023
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancerSabrina Piedimonte, Marcus Q Bernardini, Avrilynn Ding, et al.
Clinical Chemistry and Laboratory Medicine|November 16, 2022
Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypesAnnie H Ren, Panagiota S Filippou, Antoninus Soosaipillai, et al.
Clinical Proteomics|July 2, 2014
Deciphering the peptidome of urine from ovarian cancer patients and healthy controlsChristopher R Smith, Ihor Batruch, Josep Miquel Bauça, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 31, 2016
The optimal time for surgery in women with serous ovarian cancerJocelyn M Stewart, Alicia A Tone, Haiyan Jiang, et al.
Pageof 13